top of page

Alzheimer’s: Monoclonal antibodies and vaccine candidates effective in mice

Alzheimer’s disease (AD) accounts for 60–70% of all dementia cases and is the sixth Trusted Source leading cause of death in adults in the United States.

Doctors characterize the condition by a progressive decline in cognitive abilities, including memory, reasoning, thinking, and language. Although there are a few drugs that can reduce AD symptoms, there is an absence of treatments, except for the controversial drug aducanumab, which can slow the progression of the disease.


Featured Posts
Recent Posts
Search By Tags
bottom of page